Table 1.
Baseline data | CEGI group (n = 239) | Placebo group (n = 80) | Statistics | P-value |
---|---|---|---|---|
Age (yr) | 61.2±9.2 | 63.2±8.28 | t=1.74 | 0.083 |
Height (cm) | 166.3±6.94 | 165.1±7.11 | Z=1.08 | 0.282 |
Weight (kg) | 66.3±9.52 | 66.3±8.39 | Z=0.222 | 0.824 |
Sex | χ2=1.39 | 0.234 | ||
Male | 155 (64.9) | 46 (57.5) | ||
Female | 84 (35.1) | 34 (42.5) | ||
Respiratory rate (times/min) | 18.9±1.49 | 18.8±1.57 | Z=0.179 | 0.858 |
Body temperature (°C) | 36.5±0.33 | 36.5±0.32 | Z=0.304 | 0.761 |
Systolic blood pressure (mmHg) | 146.5±20.8 | 147.4±23.1 | Z=0.237 | 0.812 |
Diastolic blood pressure (mmHg) | 86.7±13 | 84.7±12.2 | Z=1.26 | 0.207 |
Time of progression (h) | 22.5±13.8 | 25.1±14.5 | Z=1.49 | 0.136 |
Allergic history | χ2=0.316 | 0.854 | ||
Yes | 7 (2.93) | 3 (3.75) | ||
No | 220 (92.1) | 72 (90.0) | ||
Unknown | 12 (5.02) | 5 (6.25) | ||
Previous medical history | χ2=0.009 | 0.926 | ||
Yes | 139 (58.2) | 47 (58.8) | ||
No | 100 (41.8) | 33 (41.2) | ||
Barthel Index scores | 64.1±18.8 | 63.38±20.2 | Z=0.117 | 0.907 |
National Institute of Health Stroke Scale scores | 8.10±2.68 | 7.69±2.10 | Z=1.07 | 0.286 |
Modified Rankin Scale scores | 2.76±0.78 | 2.80±0.85 | Z=0.219 | 0.827 |
Data are expressed as the mean ± SD except sex, allergic history, and previous medical history [n (%)]. The one-sided Cochran–Mantel– Haenszel (CMH) chi-squared test and independent t-test were used.